Talcum Powder Cancer Lawsuit

Women With Ovarian Cancer Continue To File Talcum Powder Cancer Lawsuits Against Johnson & Johnson

Women with ovarian cancer that have used Johnson's Baby Powder or another brand of talcum powder should continue to press their case

Monday, November 29, 2021 - Johnson & Johnson's move to establish a spin-off company in which to place its talcum powder business has accomplished one of its most important objectives. The legal maneuver has taken the attention off of the science that underlies more than 40,000 lawsuits filed against them. The lawsuits allege that using Johnson's Baby Powder for feminine hygiene on the peritoneal region of the body regularly and for years caused talcum powder ovarian cancer. Ovarian cancer is a death sentence where about 95% of those afflicted die within the first five years. Johnson & Johnson may be hoping their terminal illness would pressure plaintiffs to settle quickly for less money. Lawsuits also contend that the company continued to sell Johnson's Baby Powder after knowing it contained asbestos. Johnson & Johnson's bankruptcy maneuver may limit the number of funds available for those suing the company to $2 billion, the amount deposited into the new company. It may also delay the payout of funds for years as the bankruptcy and settlement matters conclude. Talcum powder cancer lawyers continue to accept cases where women that have used Johnson's Baby powder have developed ovarian cancer.

The defendant's plans, however, are in jeopardy. The Plaintiffs' Bar representing the rights of plaintiffs, in general, has succeeded in getting the talcum powder bankruptcy venue moved from North Carolina to New Jersey, where Johnson & Johnson is domiciled and where the lawsuits against them have been filed. The move also changes judges from one friendly to the controversial bankruptcy strategy, to one who will now take the next 60-days to become familiarized with it. All Johnson's baby powder ovarian cancer trials that are underway and those that were pending over the next two months have been temporarily delayed for 60-days also. The Wall Street Journal told readers that Johnson & Johnson picked the wrong state in which to file the bankruptcy, and also that North Carolina bankruptcy judge Craig Whitley said he was "obliged" to move the case.

In addition to the current talcum powder bankruptcy maneuver, two of the more interesting developments in the case are the results of a series of Daubert hearings pertaining to the science behind talcum powder testing methods and results. The other is that the Food and Drug Administration tested and found asbestos in bottles of Johnson's baby powder it purchased from American retailers and discovered they contain asbestos. Johnson & Johnson discontinued North American sales of talcum powder as a result. About two dozen cases against Johnson & Johnson have already concluded with the decisions spit roughly 50-50. The single largest plaintiff jury award was made in 2017 to Eva Echeverria, the first trial to conclude. The California woman was awarded $417 million for her pain and suffering from ovarian cancer. "Echeverria used Johnson's Baby Powder and Shower to Shower for more than 40 years. She died from ovarian cancer a month after winning the trial, according to DrugWatch.com.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.